D2‐resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy

Although adjuvant chemoradiotherapy has been an important part in the treatment of gastric cancer, whether or not adjuvant radiation can benefit patients undergoing resection with D2 lymph node dissection remains controversial. This retrospective study aimed to evaluate the role of adjuvant chemorad...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Jin, Wei, Yuehua, Zhou, Fuxiang, Dai, Jing, Zhong, Yahua, Xie, Conghua, Qin, Yue'e, Gong, Jun, Xiong, Bin, Zhou, Yunfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083730/
https://www.ncbi.nlm.nih.gov/pubmed/27666138
http://dx.doi.org/10.1002/cam4.873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083730/
https://www.ncbi.nlm.nih.gov/pubmed/27666138
http://dx.doi.org/10.1002/cam4.873

Ejemplares similares